PHOTODYNAMIC LASER THERAPY IN GYNECOLOGY

被引:10
作者
KORELL, M
UNTCH, M
ABELS, C
DELLIAN, M
KIRSCHSTEIN, M
BAUMGARTNER, R
BEYER, W
GOETZ, AE
机构
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,INST CHIRURG FORSCH,D-81366 MUNICH,GERMANY
[2] UNIV MUNICH,KLINIKUM GROSSHADERN,LASERZENTRUM UROL,D-81366 MUNICH,GERMANY
[3] UNIV MUNICH,KLINIKUM GROSSHADERN,INST ANASTHESIE,D-81366 MUNICH,GERMANY
来源
GYNAKOLOGISCH-GEBURTSHILFLICHE RUNDSCHAU | 1995年 / 35卷 / 02期
关键词
GENITAL DYSPLASIA; PHOTODYNAMIC LASER THERAPY (PDT); DELTA-AMINOLEVULINIC ACID (ALA);
D O I
10.1159/000272491
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Dysplasia of the vulva and uterine cervix are often multicentric, tend to recur and have mostly to be treated by surgical procedures. The photodynamic laser therapy (PDT) may be an alternative, which selectively destroys neoplastic tissue after topical S-aminolevulinic acid (ALA) used as a photosensitizer. Methods: We measured the distribution of fluorescence in dysplastic and nondysplastic tissue after topical application of ALA in 27 patients with dysplasia. In 3 vulvar and 2 cervical dysplasias, PDT was performed. Results: We could show a selective enrichment of endogenous porphyrins in dysplastic tissues, whereas benign tissue showed no fluorescence. The fluorescence was limited to the mucosa. The heterogenous fluorescence pattern was influenced by the duration of ALA application. In the treated patients, cytological and clinical parameters showed improvement after use of PDT. The longest recurrence-free interval from treatment up to date is 15 months (range 3-15 months). Conclusions: After first results of penetration studies and clinical follow-up, PDT after topical ALA application seems to be a good alternative to surgical procedures in dysplastic changes of the genital tract.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 24 条
[11]  
FRITSCH C, 1994, H G, V69, P713
[12]   PHOTORADIATION THERAPY OF BLADDER-TUMORS [J].
HISAZUMI, H ;
MISAKI, T ;
MIYOSHI, N ;
WHITMORE, WF .
JOURNAL OF UROLOGY, 1983, 130 (04) :685-687
[13]  
JACQUES SL, 1992, SURG CLIN N AM, V72, P531
[14]   ENDOGENOUS PROTOPORPHYRIN-IX, A CLINICALLY USEFUL PHOTOSENSITIZER FOR PHOTODYNAMIC THERAPY [J].
KENNEDY, JC ;
POTTIER, RH .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1992, 14 (04) :275-292
[15]  
MARCUS S, 1987, PHOTOCHEM PHOTOBIOL, V45, P879
[16]  
MEISELS A, 1977, CANCER, V40, P3076, DOI 10.1002/1097-0142(197712)40:6<3076::AID-CNCR2820400647>3.0.CO
[17]  
2-U
[18]   PHOTODYNAMIC THERAPY IN ONCOLOGY - MECHANISMS AND CLINICAL USE [J].
PASS, HI .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (06) :443-456
[19]   PHOTODESTRUCTION OF TUMOR-CELLS BY INDUCTION OF ENDOGENOUS ACCUMULATION OF PROTOPORPHYRIN-IX - ENHANCEMENT BY 1,10-PHENANTHROLINE [J].
REBEIZ, N ;
REBEIZ, CC ;
ARKINS, S ;
KELLEY, KW ;
REBEIZ, CA .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1992, 55 (03) :431-435
[20]  
RUMMEL HH, 1979, GEBURTSH FRAUENHEILK, V39, P503